The U.S. government sued pharmaceutical distributor AmerisourceBergen on Thursday in Pennsylvania Eastern District Court for its role in the supply chain that fueled the opioid crisis. The suit accuses Amerisource Bergen and its subsidiary units of prioritizing ‘profits over the well-being of Americans’ when it failed to monitor pharmacy orders for suspicious activity as required by the Controlled Substances Act. The suit, which seeks civil penalties, claims that AmerisourceBergen failed to report suspicious orders to authorities and continued to sell medications to pharmacies in large quantities when the company had reason to know the drugs would be diverted to illegal channels. The case is 2:22-cv-05209, United States Of America v. Amerisourcebergen Corporation et al.

This suit was surfaced by Radar, a source for high-speed legal news and litigation updates personalized to your practice. Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. Read the complaint here:

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]